Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Brassat

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Revue Neurologique|September 18, 2012
When does multiple sclerosis start? Three case reports and a review of the literatureD Brassat
Revue Neurologique|January 15, 2002
[Therapeutic indications targeting etiology. (With the exception of primary progressive forms)]D Brassat
La Revue Du Praticien|December 22, 1999
[Treatment of symptoms and relapses of multiple sclerosis]D Brassat, M Clanet
Revue Neurologique|June 23, 2012
[Pathophysiology of spasticity]P Marque, D Brassat
Current Opinion in Neurology|June 28, 2000
The management of multiple sclerosis patientsM G Clanet, D Brassat
La Revue De Medecine Interne|September 10, 1999
[Genetics of Parkinson disease]D Brassat, A Durr, Y Agid, et al.
La Revue De Medecine Interne|December 15, 2010
[Chronic headaches]G Moulis, K Delavigne, M Alvarez, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2004
Treatment response in relation to inflammatory and axonal surrogate marker in multiple sclerosisA Petzold, D Brassat, P Mas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 28, 2015
Peripheral late reactivation of a previously typical monofocal Baló's concentric sclerosis lesionJ Pique, F Bonneville, D Brassat, et al.
Neurology|September 26, 2002
Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MSD Brassat, C Recher, E Waubant, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Revue Neurologique|September 18, 2012
When does multiple sclerosis start? Three case reports and a review of the literatureD Brassat
Revue Neurologique|January 15, 2002
[Therapeutic indications targeting etiology. (With the exception of primary progressive forms)]D Brassat
La Revue Du Praticien|December 22, 1999
[Treatment of symptoms and relapses of multiple sclerosis]D Brassat, M Clanet
Revue Neurologique|June 23, 2012
[Pathophysiology of spasticity]P Marque, D Brassat
Current Opinion in Neurology|June 28, 2000
The management of multiple sclerosis patientsM G Clanet, D Brassat
La Revue De Medecine Interne|September 10, 1999
[Genetics of Parkinson disease]D Brassat, A Durr, Y Agid, et al.
La Revue De Medecine Interne|December 15, 2010
[Chronic headaches]G Moulis, K Delavigne, M Alvarez, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2004
Treatment response in relation to inflammatory and axonal surrogate marker in multiple sclerosisA Petzold, D Brassat, P Mas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 28, 2015
Peripheral late reactivation of a previously typical monofocal Baló's concentric sclerosis lesionJ Pique, F Bonneville, D Brassat, et al.
Neurology|September 26, 2002
Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MSD Brassat, C Recher, E Waubant, et al.
Pageof 5